Načítá se...
Sphingolipids in Metabolic Disease: The Good, the Bad, and the Unknown
The bioactive sphingolipid metabolites ceramide and sphingosine-1-phosphate (S1P) are a recent addition to the lipids accumulated in obesity and have emerged as important molecular players in metabolic diseases. Here we summarize evidence that dysregulation of sphingolipid metabolism correlates with...
Uloženo v:
| Vydáno v: | Cell Metab |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8269961/ https://ncbi.nlm.nih.gov/pubmed/34233172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2021.06.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|